{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-019637","form_type":"8-K","ticker":"CCRN","cik":"0001141103","company_name":"CROSS COUNTRY HEALTHCARE INC","filed_at":"2024-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.441496+00:00","generated_at":"2026-06-03T02:07:15.011169+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"medium","headline":"Cross Country Healthcare Q1 revenue down 39% YoY to $379M; net income falls 91%","bullets":["Revenue $379.2M, down 39% YoY and 8% sequentially.","Net income $2.7M, down 91% YoY; diluted EPS $0.08 vs -$0.73 in Q1 2023.","Adjusted EBITDA $15.3M (margin 4.0%), down 71% YoY; adjusted EPS $0.19.","Cash from operations $6.0M, down 87% YoY.","Gross margin 20.4%, down 200 bps YoY and 150 bps sequentially."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-019637","json":"https://secwatch.observer/filing/0001628280-24-019637.json","markdown":"https://secwatch.observer/filing/0001628280-24-019637.md","text":"https://secwatch.observer/filing/0001628280-24-019637.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024019637/0001628280-24-019637-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024019637/ccrn-20240501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T02:07:15.011169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eec48de5e783d0481862cc6ffce338e39894a779","claim":"CROSS COUNTRY HEALTHCARE INC reported first quarter ended March 31, 2024 results: revenue $379,174, net income $2,692, EPS $0.08.","evidence_excerpt":"CROSS COUNTRY HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS BOCA RATON, Fla., May 1, 2024--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2024 vs Q1 2024 vs Dollars are in thousands, except per share amounts Q1 2024 Q1 2023 Q4 2023 Revenue $ 379,174 (39) % (8) % Gross profit margin* 20.4 % (200) bps (150) bps Net income attributable to common stockholders $ 2,692 (91) % (70) % Diluted EPS $ 0.08 $ (0.73) $ (0.18)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024019637/0001628280-24-019637-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$379,174"},{"label":"Net income","value":"$2,692"},{"label":"EPS","value":"$0.08"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}